Covaxin and covisheild 50% less effective in India (B.1.617 variant)
According to a series of reports authored by a scientist at the India Council of Medical Research, the Vaccines covishield
Read MoreDefine Yourself
According to a series of reports authored by a scientist at the India Council of Medical Research, the Vaccines covishield
Read MoreFrom August 2021, vaccine manufacturer Biological E is preparing to produce 75-80 million doses per month of its recombinant protein
Read MoreAs a part of India-UK, an enhanced trade partnership held virtually between Prime Minister Narendra Modi and Prime Minister Borris
Read MoreOn Monday, the central government has asked the Bharat Biotech and Serum Institute to lower the price of their vaccine,
Read MoreA viral post has been circulating on social media, stating women above 18 years of age should not take the
Read MoreOn Saturday, Bharat Biotech announces COVAXIN will be available for the state government at Rs. 600 per dose and private
Read MoreSII lifts up the prices. Pune based SII(Serum Institute India), on 21st April announced an increase in the Covishield prices.
Read MoreIndian vaccines, since 16 January 2021 are being given to the citizens of India. Together with this, the vaccines are
Read More